NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer
暂无分享,去创建一个
R. Ferris | Q. Le | L. Mell | J. Bauman | R. Jordan | P. Torres-Saavedra | D. Blakaj | E. Yilmaz | R. Uppaluri | N. Joshi | M. Garg | D. Clump | M. Yao | N. Sen | J. Sheqwara | C. Henson | J. Harris | Josephine Chen | Srinivas Jujjuvaparu